Market Watch Over-the-counter overdose-reversal drug from nonprofit pharma group wins fast-track U.S. review A pharmaceutical nonprofit was granted priority review from the Food and Drug Administration to make an inexpensive overdose-reversal drug for use without a prescription. Harm Reduction Therapeutics…breakingnow_w51jcqDecember 26, 2022
